Form 4: Enfusion CEO Oleg Movchan Disposes of Shares Following Merger with Clearwater Analytics

Oleg Movchan, CEO of Enfusion, Inc., reports the disposal of shares following the merger with Clearwater Analytics Holdings, Inc.

Summary

• Oleg Movchan, CEO of Enfusion, filed a Form 4 indicating changes in beneficial ownership of Enfusion, Inc. securities due to the merger with Clearwater Analytics Holdings, Inc.
• The transactions occurred on April 21, 2025, and involved the disposal of Class A Common Stock.
• Movchan disposed of 1,151,818 shares, 51,808 shares, 230,039 shares, 250,000 shares and 100,000 shares of Class A Common Stock.
• The disposal was pursuant to the merger agreement dated January 10, 2025, between Enfusion and Clearwater Analytics.
• Eligible shares of Enfusion's Class A common stock were converted into the right to receive cash or shares of Clearwater Analytics common stock, subject to proration.
• As a result of the merger, Movchan ceased to be the beneficial owner of any securities of Enfusion.
• Movchan also reports transactions related to shares held by CSL Tech Holdings, LLC, where he serves as manager.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document primarily reports a transaction related to a merger. The impact depends on the perceived value of the merger for Enfusion shareholders.

Positives

• The merger with Clearwater Analytics provides liquidity to Enfusion shareholders.

Negatives

• Oleg Movchan, a key executive, no longer holds any securities in Enfusion, which could be perceived negatively by some investors.

Risks

• The Form 4 filing itself doesn't present inherent risks, but the merger's success and integration of Enfusion into Clearwater Analytics will determine future performance.
• The proration of cash and stock consideration could lead to dissatisfaction among some shareholders.

Future Outlook

The future outlook depends on the successful integration of Enfusion into Clearwater Analytics and the performance of the combined entity.

Industry Context

The merger reflects a trend of consolidation in the financial technology sector, as companies seek to expand their product offerings and market reach.

Comparison to Industry Standards

• Comparing the merger terms to similar transactions in the fintech industry would provide a benchmark for assessing the fairness of the deal.
• Companies like Black Knight and ICE have been involved in similar acquisitions, and their deal structures could offer relevant comparisons.
• The valuation multiples used in the Enfusion-Clearwater Analytics merger can be compared to industry averages to gauge whether Enfusion was acquired at a premium or discount.

Stakeholder Impact

• Shareholders of Enfusion will receive cash and/or Clearwater Analytics shares as a result of the merger.
• Employees of Enfusion may experience changes as the company integrates with Clearwater Analytics.
• Customers of Enfusion may benefit from the combined resources and capabilities of the merged entity.

Key Dates

Keywords

Enfusion, Clearwater Analytics, Merger, Oleg Movchan, Form 4, Beneficial Ownership, Share Disposal, CSL Tech Holdings, Securities, CEO